Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030
... USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that ... Read More
-
U.S. Cancer Contrast Media Market Size - By Product Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT, MRI, Mammography), Application (Breast Cancer, Bladder Cancer, Lung Cancer), End-use & Forecast, 2024 - 2032
... U.S. Cancer Contrast Media Market size is poised to expand at 4.9% CAGR between 2024 and 2032 driven by the continuous technological advancements in imaging and the launch of new products. Innovations in MRI and ... Read More
-
Global CAR T-Cell Therapy for Multiple Myeloma Market Growth (Status and Outlook) 2024-2030
... 160.4 million in 2023. With growing demand in downstream market, the CAR T-Cell Therapy for Multiple Myeloma is forecast to a readjusted size of US$ 1063 million by 2030 with a CAGR of 31.0% during ... Read More
-
Global Cancer Monoclonal Antibodies Market Growth 2024-2030
... market, the Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ 63370 million by 2030 with a CAGR of 9.5% during review period. The research report highlights the growth potential of the global ... Read More
-
Global Cancer Vaccines Market Growth 2024-2030
... Cancer Vaccines is forecast to a readjusted size of US$ 12280 million by 2030 with a CAGR of 14.9% during review period. The research report highlights the growth potential of the global Cancer Vaccines market. ... Read More
-
Global Cancer Gene Therapy Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Cancer Gene Therapy is forecast to a readjusted size of US$ 1674.2 million by 2030 with a CAGR of 18.5% during review period. The research report highlights the growth potential ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market Growth 2024-2030
... downstream market, the Breast Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Europe Colorectal Cancer Screening and Diagnostic Market: Analysis and Forecast, 2023-2033
... and is expected to reach $7.30 billion by 2033, growing at a CAGR of 5.72% during the forecast period 2023-2033. The colorectal cancer screening and diagnostic sector are influenced by various factors such as the ... Read More
-
Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Route of Administration; By Application (Lung Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032
... 2032 The global Cytotoxic Drugs market size is expected to reach USD 20.80 billion by 2032, according to a new study by Polaris Market Research. The report “Cytotoxic Drugs Market Share, Size, Trends, Industry Analysis ... Read More
-
Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033
... CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased ... Read More
-
Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032
... million in 2023 and is anticipated to reach $1,779.4 million by 2032. The anticipated growth in the next-generation breast cancer diagnostic and screening market is projected to be fueled by several factors. These include the ... Read More
-
Acute Myeloid Leukemia Global Market Report 2024
... DC Regimen; AVD Regimen; VCD Regimen4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; ClinicsCovering: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation) Acute Myeloid Leukemia Global Market Report ... Read More
-
Global Vaccine Adjuvants Market Size study&Forecast, byType (Pathogen, Adjuvant emulsion, Particulate, Combination, Others), by Application (Infectious diseases, Cancer, Others), by Administration (Oral, Intradermal, Intranasal, Intramuscular, Others) and Regional Analysis, 2023-2030
... valued at approximately USD1.62 billion in 2022 andis anticipated to grow with a healthy growth rate of more than 2.3%duringthe forecast period 2023-2030.Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness ... Read More
-
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024
... - Global Clinical Trials Review, 2024 provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
... (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Tumor Ablation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 10.10% during the forecast period (2024-2029). Key Highlights The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many healthcare facilities, ... Read More
-
Community Oncology Services Global Market Report 2024
... Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer 3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology Covering: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology ... Read More
-
Cancer Monoclonal Antibodies Global Market Report 2024
... Cancer 3) By End-User: Hospitals; Research Laboratories Covering: F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Bristol Myers Squibb Company; Johnson & Johnson; Amgen Inc. Cancer Monoclonal Antibodies Global Market Report 2024 from The Business ... Read More
-
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
... 2020). NSCLC begins when healthy cells that make up the lining of the lungs change and grow out of control, forming a tumor. NSCLC can begin anywhere in the lungs and can be categorized into ... Read More
-
Global AI in Cancer Diagnostics Market (2023-2028) by Components, Cancer Type, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... 147.61 Mn in 2023 and is expected to reach USD 400.91 Mn by 2028 growing at a CAGR of 22.12%. Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2024
... Surgical Centers; Multispecialty Clinics; Cancer Research Centers; Cancer Rehabilitation CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG Chemotherapy-Induced Anemia Global Market Report 2024 from The Business Research ... Read More
-
Cervical Cancer Vaccine Global Market Report 2024
... Johnson & Johnson; Merck & Co Inc.; Novartis AG; Sanofi Pasteur Cervical Cancer Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
... to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Penile Cancer Global Market Report 2024
... Radiation Therapy; Chemotherapy; Biological Therapy; Surgery3) By Diagnostic Test: Biopsy; Ultrasound; Imaging Tests4) By Application: Hospital; ClinicsCovering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company; Fresenius Kabi AG Penile Cancer Global Market ... Read More
Research Assistance
